{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T21:47:16Z","timestamp":1779400036145,"version":"3.53.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"DOI":"10.1007\/s11912-025-01671-5","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T16:54:52Z","timestamp":1744131292000},"page":"625-633","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Evaluation and Prognostic Impact of Nutrition in Patients with Acute Leukemia: A Narrative Review"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2850-648X","authenticated-orcid":false,"given":"Vanessa","family":"Fuchs-Tarlovsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2153-1073","authenticated-orcid":false,"given":"Karolina","family":"Alvarez-Altamirano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7283-7019","authenticated-orcid":false,"given":"Fernand","family":"Vedrenne-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"1671_CR1","unstructured":"Chennamadhavuni A et al. Leukemia, in StatPearls. 2025, StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC.: Treasure Island (FL)."},{"issue":"10230","key":"1671_CR2","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1016\/S0140-6736(19)33018-1","volume":"395","author":"F Malard","year":"2020","unstructured":"Malard F, Mohty M. Acute lymphoblastic leukaemia. Lancet. 2020;395(10230):1146\u201362.","journal-title":"Lancet"},{"issue":"16","key":"1671_CR3","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1080\/14656566.2017.1391216","volume":"18","author":"T Murphy","year":"2017","unstructured":"Murphy T, Yee KWL. Cytarabine and Daunorubicin for the treatment of acute myeloid leukemia. Expert Opin Pharmacother. 2017;18(16):1765\u201380.","journal-title":"Expert Opin Pharmacother"},{"issue":"10","key":"1671_CR4","doi-asserted-by":"publisher","first-page":"3091","DOI":"10.3324\/haematol.2024.285455","volume":"109","author":"A Rashidi","year":"2024","unstructured":"Rashidi A. Cachexia during anti-leukemia chemotherapy: it is not just the chemo. Haematologica. 2024;109(10):3091\u20133.","journal-title":"Haematologica"},{"issue":"11","key":"1671_CR5","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.clnu.2023.09.021","volume":"42","author":"SA P\u00f6tgens","year":"2023","unstructured":"P\u00f6tgens SA, et al. Gut microbiota alterations induced by intensive chemotherapy in acute myeloid leukaemia patients are associated with gut barrier dysfunction and body weight loss. Clin Nutr. 2023;42(11):2214\u201328.","journal-title":"Clin Nutr"},{"issue":"5","key":"1671_CR6","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1177\/0148607109341804","volume":"33","author":"DA August","year":"2009","unstructured":"August DA, Huhmann MB. A.S.P.E.N. Clinical guidelines: nutrition support therapy during adult anticancer treatment and in hematopoietic cell transplantation. JPEN J Parenter Enter Nutr. 2009;33(5):472\u2013500.","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"1671_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.nut.2017.04.011","volume":"41","author":"E Deluche","year":"2017","unstructured":"Deluche E, et al. Assessment of the nutritional status of adult patients with acute myeloid leukemia during induction chemotherapy. Nutrition. 2017;41:120\u20135.","journal-title":"Nutrition"},{"issue":"3","key":"1671_CR8","first-page":"703","volume":"11","author":"A Turedi","year":"2010","unstructured":"Turedi A, Demir C, Dilek I. Assessment of malnutrition in adult acute leukemia cases. Asian Pac J Cancer Prev. 2010;11(3):703\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"1671_CR9","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1111\/ecc.12262","volume":"24","author":"Z Malihi","year":"2015","unstructured":"Malihi Z, et al. The effect of dietary intake changes on nutritional status in acute leukaemia patients after first induction chemotherapy. Eur J Cancer Care (Engl). 2015;24(4):542\u201352.","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"5","key":"1671_CR10","doi-asserted-by":"publisher","first-page":"107074","DOI":"10.1016\/j.ejso.2023.107074","volume":"50","author":"J Arends","year":"2024","unstructured":"Arends J. Malnutrition in cancer patients: causes, consequences and treatment options. Eur J Surg Oncol. 2024;50(5):107074.","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"1671_CR11","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3109\/10428194.2013.853766","volume":"55","author":"A Esfahani","year":"2014","unstructured":"Esfahani A, et al. Nutritional assessment of patients with acute leukemia during induction chemotherapy: association with hospital outcomes. Leuk Lymphoma. 2014;55(8):1743\u201350.","journal-title":"Leuk Lymphoma"},{"key":"1671_CR12","doi-asserted-by":"publisher","first-page":"127","DOI":"10.4999\/uhod.237189","volume":"33","author":"F Yilmaz","year":"2023","unstructured":"Yilmaz F. The relationship between GLIM criteria and recovery times in the leukemia treatment process. Int J Hematol Oncol. 2023;33:127\u201334.","journal-title":"Int J Hematol Oncol"},{"issue":"6","key":"1671_CR13","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/(SICI)1097-0142(19980315)82:6<1071::AID-CNCR9>3.0.CO;2-H","volume":"82","author":"KM Eriksson","year":"1998","unstructured":"Eriksson KM, Cederholm T, Palmblad JE. Nutrition and acute leukemia in adults: relation between nutritional status and infectious complications during remission induction. Cancer. 1998;82(6):1071\u20137.","journal-title":"Cancer"},{"key":"1671_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4274\/tmsj.galenos.2022.09.01.03","volume":"9","author":"E Cengiz","year":"2022","unstructured":"Cengiz E, et al. Effects of malnutrition on the prognosis of pediatric acute lymphoblastic leukemia patients. TURKISH Med STUDENT J. 2022;9:14\u20139.","journal-title":"TURKISH Med STUDENT J"},{"issue":"2","key":"1671_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000449451","volume":"69","author":"A Baumgartner","year":"2016","unstructured":"Baumgartner A, et al. Association of nutritional parameters with clinical outcomes in patients with acute myeloid leukemia undergoing Haematopoietic stem cell transplantation. Ann Nutr Metab. 2016;69(2):89\u201398.","journal-title":"Ann Nutr Metab"},{"key":"1671_CR16","unstructured":"Vakiti A, Reynolds SB, Mewawalla P. Acute Myeloid Leukemia, in StatPearls. 2025, StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC.: Treasure Island (FL)."},{"issue":"8","key":"1671_CR17","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00277-021-04568-y","volume":"100","author":"A Wysocka-S\u0142owik","year":"2021","unstructured":"Wysocka-S\u0142owik A, et al. Oral mucositis in patients with acute myeloid leukemia treated with allogeneic hematopoietic stem cell transplantation in relation to the conditioning used prior to transplantation. Ann Hematol. 2021;100(8):2079\u201386.","journal-title":"Ann Hematol"},{"issue":"7","key":"1671_CR18","first-page":"e26712","volume":"14","author":"EC Becker","year":"2022","unstructured":"Becker EC, Tafader A, Bath RK. Neutropenic Enterocolitis in a patient with acute myeloid leukemia. Cureus. 2022;14(7):e26712.","journal-title":"Cureus"},{"key":"1671_CR19","doi-asserted-by":"crossref","unstructured":"Gallardo-Rodr\u00edguez AG et al. Cross-Training and resistance training in adults with type B acute lymphoblastic leukemia during the induction phase: A randomized blind pilot study. J Clin Med, 2023. 12(15).","DOI":"10.3390\/jcm12155008"},{"issue":"12","key":"1671_CR20","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1634\/theoncologist.2015-0164","volume":"21","author":"SC Howard","year":"2016","unstructured":"Howard SC, et al. Preventing and managing toxicities of High-Dose methotrexate. Oncologist. 2016;21(12):1471\u201382.","journal-title":"Oncologist"},{"key":"1671_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.critrevonc.2015.01.002","volume":"100","author":"A Shrivastava","year":"2016","unstructured":"Shrivastava A, et al. Recent developments in L-asparaginase discovery and its potential as anticancer agent. Crit Rev Oncol Hematol. 2016;100:1\u201310.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"3","key":"1671_CR22","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1097\/MPG.0000000000003334","volume":"74","author":"EE Mauney","year":"2022","unstructured":"Mauney EE, et al. Clinical characteristics and Short-Term outcomes of children with Asparaginase-Associated pancreatitis. J Pediatr Gastroenterol Nutr. 2022;74(3):402\u20137.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1671_CR23","first-page":"1327","volume":"15","author":"HR Gonz\u00e1lez","year":"2021","unstructured":"Gonz\u00e1lez HR, et al. Malnutrition in paediatric patients with leukaemia and lymphoma: a retrospective cohort study. Ecancermedicalscience. 2021;15:1327.","journal-title":"Ecancermedicalscience"},{"key":"1671_CR24","doi-asserted-by":"publisher","first-page":"910770","DOI":"10.3389\/fonc.2022.910770","volume":"12","author":"P Bossi","year":"2022","unstructured":"Bossi P, et al. Malnutrition management in oncology: an expert view on controversial issues and future perspectives. Front Oncol. 2022;12:910770.","journal-title":"Front Oncol"},{"key":"1671_CR25","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.clnesp.2024.05.020","volume":"62","author":"B Cucchiaro","year":"2024","unstructured":"Cucchiaro B, et al. Malnutrition and cachexia are associated with poor CAR T-cell therapy outcomes including survival. Clin Nutr ESPEN. 2024;62:206\u201315.","journal-title":"Clin Nutr ESPEN"},{"key":"1671_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1182\/blood-2020-134187","volume":"136","author":"D Brauer","year":"2020","unstructured":"Brauer D, et al. Prognostic impact of nutritional status at diagnosis and weight changes in acute myeloid leukemia patients receiving allogeneic hematopoietic stem cell transplantation. Blood. 2020;136:32\u20133.","journal-title":"Blood"},{"issue":"6","key":"1671_CR27","first-page":"762","volume":"25","author":"B Wang","year":"2013","unstructured":"Wang B, et al. Nutritional assessment with different tools in leukemia patients after hematopoietic stem cell transplantation. Chin J Cancer Res. 2013;25(6):762\u20139.","journal-title":"Chin J Cancer Res"},{"issue":"4","key":"1671_CR28","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1007\/s11670-012-0267-8","volume":"24","author":"P Liu","year":"2012","unstructured":"Liu P, et al. NRS2002 assesses nutritional status of leukemia patients undergoing hematopoietic stem cell transplantation. Chin J Cancer Res. 2012;24(4):299\u2013303.","journal-title":"Chin J Cancer Res"},{"key":"1671_CR29","doi-asserted-by":"publisher","first-page":"112567","DOI":"10.1016\/j.nut.2024.112567","volume":"128","author":"V Fuchs-Tarlovsky","year":"2024","unstructured":"Fuchs-Tarlovsky V, et al. Translation, cultural adaptation, and assessment of the linguistic and content validity of the PG-SGA to the Spanish linguistic setting by cancer patients and healthcare professionals. Nutrition. 2024;128:112567.","journal-title":"Nutrition"},{"issue":"3","key":"1671_CR30","doi-asserted-by":"publisher","first-page":"e9663","DOI":"10.1097\/MD.0000000000009663","volume":"97","author":"J Li","year":"2018","unstructured":"Li J, et al. Severe malnutrition evaluated by patient-generated subjective global assessment results in poor outcome among adult patients with acute leukemia: A retrospective cohort study. Med (Baltim). 2018;97(3):e9663.","journal-title":"Med (Baltim)"},{"issue":"3","key":"1671_CR31","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3390\/nu8030163","volume":"8","author":"U Gr\u00f6ber","year":"2016","unstructured":"Gr\u00f6ber U, et al. Micronutrients in oncological intervention. Nutrients. 2016;8(3):163.","journal-title":"Nutrients"},{"issue":"02","key":"1671_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1055\/s-0042-1742665","volume":"43","author":"S Maurya","year":"2022","unstructured":"Maurya S, et al. Assessment of baseline nutritional status, vitamin B12, and folate levels in patients with acute leukemia and their effect on initial treatment outcome: A prospective observational study. Indian J Med Paediatr Oncol. 2022;43(02):171\u20136.","journal-title":"Indian J Med Paediatr Oncol"},{"issue":"1","key":"1671_CR33","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1038\/s41598-020-59101-4","volume":"10","author":"K Annu","year":"2020","unstructured":"Annu K, et al. Role of vitamins A and D in BCR-ABL Arf(-\/-) acute lymphoblastic leukemia. Sci Rep. 2020;10(1):2359.","journal-title":"Sci Rep"},{"issue":"4","key":"1671_CR34","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1002\/cncr.28368","volume":"120","author":"HJ Lee","year":"2014","unstructured":"Lee HJ, et al. Low 25(OH) vitamin D3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia. Cancer. 2014;120(4):521\u20139.","journal-title":"Cancer"},{"issue":"1","key":"1671_CR35","first-page":"10","volume":"29","author":"A Naz","year":"2013","unstructured":"Naz A, et al. Vitamin D levels in patients of acute leukemia before and after remission-induction therapy. Pak J Med Sci. 2013;29(1):10\u20134.","journal-title":"Pak J Med Sci"},{"key":"1671_CR36","doi-asserted-by":"publisher","first-page":"3067126","DOI":"10.1155\/2018\/3067126","volume":"2018","author":"LM Oliveira","year":"2018","unstructured":"Oliveira LM, Teixeira FME, Sato MN. Impact of retinoic acid on immune cells and inflammatory diseases. Mediators Inflamm. 2018;2018:3067126.","journal-title":"Mediators Inflamm"},{"issue":"1","key":"1671_CR37","doi-asserted-by":"publisher","first-page":"7","DOI":"10.2165\/00002018-199005010-00003","volume":"5","author":"J Stentoft","year":"1990","unstructured":"Stentoft J. The toxicity of cytarabine. Drug Saf. 1990;5(1):7\u201327.","journal-title":"Drug Saf"},{"key":"1671_CR38","doi-asserted-by":"publisher","first-page":"101205","DOI":"10.1016\/j.mam.2023.101205","volume":"93","author":"R Mattioli","year":"2023","unstructured":"Mattioli R, et al. Doxorubicin and other anthracyclines in cancers: activity, chemoresistance and its overcoming. Mol Aspects Med. 2023;93:101205.","journal-title":"Mol Aspects Med"},{"key":"1671_CR39","unstructured":"Fludarabine. LiverTox: clinical and research information on Drug-Induced liver injury. National Institute of Diabetes and Digestive and Kidney Diseases: Bethesda (MD); 2012."},{"issue":"11","key":"1671_CR40","doi-asserted-by":"publisher","first-page":"e879","DOI":"10.1016\/S2352-3026(23)00273-9","volume":"10","author":"M L\u00fcbbert","year":"2023","unstructured":"L\u00fcbbert M, et al. 10-day decitabine versus 3\u2008+\u20087 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial. Lancet Haematol. 2023;10(11):e879\u201389.","journal-title":"Lancet Haematol"},{"key":"1671_CR41","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.2147\/DDDT.S198950","volume":"13","author":"F Zhou","year":"2019","unstructured":"Zhou F, Ge Z, Chen B. Quizartinib (AC220): a promising option for acute myeloid leukemia. Drug Des Devel Ther. 2019;13:1117\u201325.","journal-title":"Drug Des Devel Ther"},{"key":"1671_CR42","doi-asserted-by":"publisher","first-page":"151","DOI":"10.2147\/CMAR.S196568","volume":"12","author":"L Fletcher","year":"2020","unstructured":"Fletcher L, Joshi SK, Traer E. Profile of Quizartinib for the treatment of adult patients with relapsed\/refractory FLT3-ITD-Positive acute myeloid leukemia: evidence to date. Cancer Manag Res. 2020;12:151\u201363.","journal-title":"Cancer Manag Res"},{"issue":"2","key":"1671_CR43","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.beha.2019.05.008","volume":"32","author":"VA Guerra","year":"2019","unstructured":"Guerra VA, DiNardo C, Konopleva M. Venetoclax-based therapies for acute myeloid leukemia. Best Pract Res Clin Haematol. 2019;32(2):145\u201353.","journal-title":"Best Pract Res Clin Haematol"},{"issue":"4","key":"1671_CR44","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1080\/13543784.2023.2193679","volume":"32","author":"A Bruzzese","year":"2023","unstructured":"Bruzzese A, et al. Venetoclax in acute myeloid leukemia. Expert Opin Investig Drugs. 2023;32(4):271\u20136.","journal-title":"Expert Opin Investig Drugs"},{"key":"1671_CR45","unstructured":"Awosika AO, Below J, Das JM. Vincristine, in StatPearls. 2025, StatPearls Publishing Copyright \u00a9 2025, StatPearls Publishing LLC.: Treasure Island (FL)."},{"issue":"11","key":"1671_CR46","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S1470-2045(10)70114-5","volume":"11","author":"H Inaba","year":"2010","unstructured":"Inaba H, Pui CH. Glucocorticoid use in acute lymphoblastic leukaemia. Lancet Oncol. 2010;11(11):1096\u2013106.","journal-title":"Lancet Oncol"},{"issue":"6","key":"1671_CR47","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1177\/1078155217710553","volume":"24","author":"S Cuellar","year":"2018","unstructured":"Cuellar S, et al. BCR-ABL1 tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia. J Oncol Pharm Pract. 2018;24(6):433\u201352.","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"1671_CR48","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41392-023-01469-6","volume":"8","author":"S Shyam Sunder","year":"2023","unstructured":"Shyam Sunder S, Sharma UC, Pokharel S. Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management. Signal Transduct Target Ther. 2023;8(1):262.","journal-title":"Signal Transduct Target Ther"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01671-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11912-025-01671-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-025-01671-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T05:04:26Z","timestamp":1747285466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11912-025-01671-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["1671"],"URL":"https:\/\/doi.org\/10.1007\/s11912-025-01671-5","relation":{},"ISSN":["1534-6269"],"issn-type":[{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"assertion":[{"value":"21 March 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}